AVGN Avigen (MM)

ALAMEDA, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Avigen, Inc. (NASDAQ:AVGN), a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, announced today that President and Chief Executive Officer, Kenneth Chahine, Ph.D., J.D., will present at the BIO CEO and Investor Conference. Avigen will conduct a live audio webcast of Dr. Chahine's presentation, at the Millennium Hotel in New York on Tuesday, February 14, 2006 from 3:30pm-4:00pm EST. This call is being webcast live and can be accessed through Avigen's Web site at http://www.avigen.com/. The webcast replay will be available approximately 1 hour after the webcast presentation ends at Avigen's Web site at http://www.avigen.com/. FCMN Contact: mcoffee@avigen.com DATASOURCE: Avigen, Inc. CONTACT: Michael Coffee, Chief Business Officer of Avigen, Inc., +1-510-748-7372, or Web site: http://www.avigen.com/

Copyright